Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- Check5 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating restricted access to the study record rather than listing study details or results.SummaryDifference18%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision tag 'Revision: v3.6.6' was added and the previous 'Revision: v3.6.5' tag was removed. This indicates an update to the page's version.SummaryDifference0.0%

- Check33 days agoChange Detected2018 ( U.S. NIH Grant/Contract ) was added to the study's identifiers, signaling NIH funding attribution. This addition adds funding-related metadata to the record without changing the study's design or reported results.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page's revision label changed from v3.6.4 to v3.6.5, signaling a small update to the Study Details page.SummaryDifference0.0%

- Check55 days agoChange DetectedThe study record now includes an EU CTIS trial number (2024-514479-16-00) and recent update dates, representing regulatory identifiers and the latest data refresh for the record.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a minor software version update on the page.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.